RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Enveric Biosciences Stock

Enveric Biosciences Net Income 2024

Enveric Biosciences Net Income

-18.92 M USD

Ticker

ENVB

ISIN

US29405E2081

WKN

A3DMHB

In 2024, Enveric Biosciences's profit amounted to -18.92 M USD, a 8.4% increase from the -17.46 M USD profit recorded in the previous year.

The Enveric Biosciences Net Income history

YEARNET INCOME (undefined USD)
2029e-
2028e-
2027e-
2026e-15,922.2
2025e-12,828.74
2024e-18,924.67
2023-17,458.76
2022-18,800
2021-48,980
2020-6,860
2019-6,030
2018-19,480
2017-11,160
2016-2,780
2015-1,890
2014-30
2013-
2012-20
2011-30
2010-40
2009-60
2008-140
2007810
2006-350
2005-80
2004-160

Enveric Biosciences Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Enveric Biosciences, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Enveric Biosciences from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Enveric Biosciences’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Enveric Biosciences. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Enveric Biosciences’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Enveric Biosciences’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Enveric Biosciences’s growth potential.

Enveric Biosciences Revenue, EBIT and net profit per share

DateEnveric Biosciences RevenueEnveric Biosciences EBITEnveric Biosciences Net Income
2029e51 M undefined0 undefined0 undefined
2028e25.5 M undefined-4.28 M undefined0 undefined
2027e15.3 M undefined-11.12 M undefined0 undefined
2026e0 undefined-22.51 M undefined-15.92 M undefined
2025e0 undefined-19.9 M undefined-12.83 M undefined
2024e0 undefined-18.34 M undefined-18.92 M undefined
20230 undefined-16.45 M undefined-17.46 M undefined
20220 undefined-19.97 M undefined-18.8 M undefined
20210 undefined-25.29 M undefined-48.98 M undefined
20200 undefined-5.62 M undefined-6.86 M undefined
201939.91 M undefined-6.32 M undefined-6.03 M undefined
201843 M undefined2.22 M undefined-19.48 M undefined
201748.59 M undefined-10.42 M undefined-11.16 M undefined
201636.15 M undefined-3.79 M undefined-2.78 M undefined
201515.98 M undefined-210,000 undefined-1.89 M undefined
20140 undefined-30,000 undefined-30,000 undefined
20130 undefined-30,000 undefined0 undefined
20120 undefined-20,000 undefined-20,000 undefined
20110 undefined-30,000 undefined-30,000 undefined
20100 undefined-40,000 undefined-40,000 undefined
20090 undefined-60,000 undefined-60,000 undefined
20080 undefined-150,000 undefined-140,000 undefined
20070 undefined-210,000 undefined810,000 undefined
20060 undefined-230,000 undefined-350,000 undefined
20050 undefined-240,000 undefined-80,000 undefined
20041.11 M undefined-150,000 undefined-160,000 undefined

Enveric Biosciences stock margins

The Enveric Biosciences margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Enveric Biosciences. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Enveric Biosciences.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Enveric Biosciences's sales revenue. A higher gross margin percentage indicates that the Enveric Biosciences retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Enveric Biosciences's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Enveric Biosciences's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Enveric Biosciences's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Enveric Biosciences. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Enveric Biosciences's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Enveric Biosciences Margin History

Enveric Biosciences Gross marginEnveric Biosciences Profit marginEnveric Biosciences EBIT marginEnveric Biosciences Profit margin
2029e20.42 %0 %0 %
2028e20.42 %-16.8 %0 %
2027e20.42 %-72.67 %0 %
2026e20.42 %0 %0 %
2025e20.42 %0 %0 %
2024e20.42 %0 %0 %
202320.42 %0 %0 %
202220.42 %0 %0 %
202120.42 %0 %0 %
202020.42 %0 %0 %
201920.42 %-15.84 %-15.11 %
201820.88 %5.16 %-45.3 %
201721.07 %-21.44 %-22.97 %
201619.17 %-10.48 %-7.69 %
201535.98 %-1.31 %-11.83 %
201420.42 %0 %0 %
201320.42 %0 %0 %
201220.42 %0 %0 %
201120.42 %0 %0 %
201020.42 %0 %0 %
200920.42 %0 %0 %
200820.42 %0 %0 %
200720.42 %0 %0 %
200620.42 %0 %0 %
200520.42 %0 %0 %
200490.09 %-13.51 %-14.41 %

Enveric Biosciences Aktienanalyse

What does Enveric Biosciences do?

Enveric Biosciences ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Net Income Details

Understanding Enveric Biosciences's Profit Margins

The profit margins of Enveric Biosciences represent the net income earned after deducting all operational expenses, costs, and taxes from the revenue. This figure is a clear indicator of Enveric Biosciences's financial health, operational efficiency, and profitability. Higher profit margins signify better cost management and income generation capabilities.

Year-to-Year Comparison

Evaluating Enveric Biosciences's profit on a yearly basis can offer significant insights into its financial growth, stability, and trends. A consistent increase in profit suggests improved operational efficiency, cost management, or increased revenue, while a decrease may indicate rising costs, declining sales, or operational challenges.

Impact on Investments

Enveric Biosciences's profit figures are critical for investors who are aiming to understand the company's financial standing and future growth prospects. Increased profits often lead to higher stock valuations, boosting investor confidence and attracting more investments.

Interpreting Profit Fluctuations

When Enveric Biosciences’s profit increases, it often indicates enhanced operational efficiency or increased sales. In contrast, a decline in profit can signal operational inefficiencies, increased costs, or competitive pressures, necessitating strategic interventions to boost profitability.

Frequently Asked Questions about Enveric Biosciences stock

How much profit has Enveric Biosciences made this year?

Enveric Biosciences has made -18.92 M USD this year.

How has the profit developed compared to last year?

The profit has increased by 8.4% compared to last year increased

What impact do the earnings have on the shareholders?

An increase in earnings is usually seen as a positive indicator for shareholders as it means that the company is generating profits.

How does Enveric Biosciences publish its earnings?

Enveric Biosciences publishes its earnings in the form of quarterly or annual reports.

Which financial indicators are included in the quarterly or annual reports?

The quarterly or annual reports contain information about sales and profit, cash flow, balance sheet, and other fundamentals.

Why is it important for investors to know the earnings of Enveric Biosciences?

The profits of Enveric Biosciences are an important indicator of the financial health of the company and can help investors decide whether they want to invest in the company or not.

How can one learn more about the earnings of Enveric Biosciences?

You can learn more about the earnings of Enveric Biosciences by reviewing the quarterly or annual reports or following the company presentations.

How much dividend does Enveric Biosciences pay?

Over the past 12 months, Enveric Biosciences paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Enveric Biosciences is expected to pay a dividend of 0 USD.

What is the dividend yield of Enveric Biosciences?

The current dividend yield of Enveric Biosciences is .

When does Enveric Biosciences pay dividends?

Enveric Biosciences pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Enveric Biosciences?

Enveric Biosciences paid dividends every year for the past 0 years.

What is the dividend of Enveric Biosciences?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Enveric Biosciences located?

Enveric Biosciences is assigned to the 'Health' sector.

Wann musste ich die Aktien von Enveric Biosciences kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Enveric Biosciences from 9/28/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 9/28/2024.

When did Enveric Biosciences pay the last dividend?

The last dividend was paid out on 9/28/2024.

What was the dividend of Enveric Biosciences in the year 2023?

In the year 2023, Enveric Biosciences distributed 0 USD as dividends.

In which currency does Enveric Biosciences pay out the dividend?

The dividends of Enveric Biosciences are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Enveric Biosciences

Our stock analysis for Enveric Biosciences Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Enveric Biosciences Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.